Arena Ulcerative Colitis Study
Posted Date: Mar 31, 2021
- Investigator: Loren Brook
- Specialties:
- Type of Study: Drug
A 12 week study to investigate the safety and efficacy of Etrasimod in patients with moderately to severely active Ulcerative Colitis. Participants who complete the study may be eligible to participate in a long term extension open label study.
Criteria:
Moderately To Severely Active Ulcerative Colitis Defined As A 3-Component Mayo Clinic Score, Evidence Of Colonic Ulcerative Colitis Activity On Endoscopy
Keywords:
Ulcerative Colitis, Pancolitis
For More Information:
Missy Randolph
513-558-5529
randollj@ucmail.uc.edu